FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Carl Plager

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Drug Evaluation

Co-author Network

Publications

TOP 3
Kevin B Kim; Sewa S Legha; Rene Gonzalez; Clay M Anderson; Marcella M Johnson; Ping Liu; Nicholas E Papadopoulos; Omar Eton; Carl Plager; Antonio C Buzaid; Victor G Prieto; Wen-Jen Hwu; Angela M Frost; Gladys Alvarado; Patrick Hwu; Merrick I Ross; jeffrey gershenwald; Jeffrey E Lee; Paul F Mansfield; Robert S Benjamin; Agop Bedikian
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
Ashish M Kamat; Carl Plager; Pheroze Tamboli; Nho Tran; Curtis A Pettaway
Metastatic epithelioid hemangioendothelioma of the penis managed with surgery and interferon-alpha.
Agop Bedikian; Carl Plager; Nicholas Papadopoulos; Omar Eton; Julie A Ellerhorst; Theresa Smith
Phase II evaluation of paclitaxel by short intravenous infusion in metastatic melanoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Carl Plager (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Kevin B Kim; Sewa S Legha; Rene Gonzalez; Clay M Anderson; Marcella M Johnson; Ping Liu; Nicholas E Papadopoulos; Omar Eton; Carl Plager; Antonio C Buzaid; Victor G Prieto; Wen-Jen Hwu; Angela M Frost; Gladys Alvarado; Patrick Hwu; Merrick I Ross; jeffrey gershenwald; Jeffrey E Lee; Paul F Mansfield; Robert S Benjamin; Agop Bedikian
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
Melanoma research 2009;19(1):42-9.
2004: Ashish M Kamat; Carl Plager; Pheroze Tamboli; Nho Tran; Curtis A Pettaway
Metastatic epithelioid hemangioendothelioma of the penis managed with surgery and interferon-alpha.
The Journal of urology 2004;171(5):1886-7.
2004: Agop Bedikian; Carl Plager; Nicholas Papadopoulos; Omar Eton; Julie A Ellerhorst; Theresa Smith
Phase II evaluation of paclitaxel by short intravenous infusion in metastatic melanoma.
Melanoma research 2004;14(1):63-6.
2003: Agop Bedikian; Nicholas Papadopoulos; Carl Plager; Omar Eton; Sigrid E Ring
Phase II evaluation of temozolomide in metastatic choroidal melanoma.
Melanoma research 2003;13(3):303-6.
2002: Funda Meric; Kenneth R Hess; Datla G K Varma; Kelly K Hunt; Peter W T Pisters; Kresimira M Milas; Shreyaskumar R Patel; Robert S Benjamin; Carl Plager; Nicholas E Papadopoulos; Michael A Burgess; Raphael E Pollock; Barry W Feig
Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas.
Cancer 2002;95(5):1120-6.
2002: Malcolm M Bilimoria; Daniel J Holtz; Nadeem Q Mirza; Barry W Feig; Peter W T Pisters; Shreyaskumar Patel; Raphael E Pollock; Robert S Benjamin; Nicholas E Papadopoulos; Carl Plager; Anne Murphy; Janet R Griffin; Michael A Burgess; Kelly K Hunt
Tumor volume as a prognostic factor for sarcomatosis.
Cancer 2002;94(9):2441-6.
2002: Omar Eton; Sewa S Legha; Agop Bedikian; J Jack Lee; Antonio C Buzaid; Cynthia Hodges; Sigrid E Ring; Nicholas E Papadopoulos; Carl Plager; Mary Jo East; Fenghuang Zhan; Robert S Benjamin
Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(8):2045-52.
2002: Julie A Ellerhorst; Agop Bedikian; Teresa M Smith; Nicholas E Papadopoulos; Carl Plager; Omar Eton
Phase II trial of 9-nitrocamptothecin (RFS 2000) for patients with metastatic cutaneous or uveal melanoma.
Anti-cancer drugs 2002;13(2):169-72.
2001: Shreyaskumar R Patel; Jan Jenkins; Nicholas Papadopolous; Michael A Burgess; Carl Plager; Jordan U Gutterman; Robert S Benjamin
Pilot study of vitaxin--an angiogenesis inhibitor-in patients with advanced leiomyosarcomas.
Cancer 2001;92(5):1347-8.
2001: Shreyaskumar R Patel; Varsha Gandhi; Jan Jenkins; Nicholas Papadopolous; Michael A Burgess; Carl Plager; William Plunkett; Robert S Benjamin
Phase II clinical investigation of gemcitabine in advanced soft tissue sarcomas and window evaluation of dose rate on gemcitabine triphosphate accumulation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(15):3483-9.
2001: Agop Bedikian; Carl Plager; Jubilee R Stewart; Catherine A O'Brian; S K Herdman; Merrick Ross; Nicholas Papadopoulos; Omar Eton; Julie A Ellerhorst; Theresa Smith
Phase II evaluation of bryostatin-1 in metastatic melanoma.
Melanoma research 2001;11(2):183-8.
2000: Funda Meric; M Milas; Kelly K Hunt; Kenneth R Hess; Peter W T Pisters; G Hildebrandt; Shreyaskumar R Patel; Robert S Benjamin; Carl Plager; Nicholas Papadopolous; Michael A Burgess; Raphael E Pollock; Barry W Feig
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(19):3378-83.
2000: Agop Bedikian; Carl Plager; Nicholas Papadopoulos; Julie A Ellerhorst; Theresa Smith; Robert S Benjamin
A phase II evaluation of bexarotene (Targretin) capsules in patients with metastatic melanoma.
Oncology reports 2000;7(4):883-6.
1999: Agop Bedikian; Sewa S Legha; Omar Eton; Antonio C Buzaid; Nicholas Papadopoulos; Carl Plager; S McIntyre; J Viallet
Phase II trial of escalated dose of tirapazamine combined with cisplatin in advanced malignant melanoma.
Anti-cancer drugs 1999;10(8):735-9.
1999: Jason Fleming; Russell S Berman; S C Cheng; NP Chen; Kelly K Hunt; Barry W Feig; Paula M Respondek; Alan W Yasko; Alan Pollack; Shreyaskumar R Patel; Michael A Burgess; Nicholas E Papadopoulos; Carl Plager; Gunar K Zagars; Robert S Benjamin; Raphael E Pollock; Peter W T Pisters
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(9):2772-80.
1998: Antonio C Buzaid; M Colome; Agop Bedikian; Omar Eton; Sewa S Legha; Nicholas Papadopoulos; Carl Plager; Merrick Ross; Jeffrey E Lee; Paul Mansfield; J Rice; Sigrid E Ring; J J Lee; E Strom; Robert Benjamin
Phase II study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases.
Melanoma research 1998;8(6):549-56.
1998: Shreyaskumar R Patel; Saroj Vadhan-Raj; Michael A Burgess; Carl Plager; Nicholas Papadopolous; Jan Jenkins; Robert S Benjamin
Results of two consecutive trials of dose-intensive chemotherapy with doxorubicin and ifosfamide in patients with sarcomas.
American journal of clinical oncology 1998;21(3):317-21.
1998: Sewa S Legha; Sigrid E Ring; Omar Eton; Agop Bedikian; Antonio C Buzaid; Carl Plager; Nicholas Papadopoulos
Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(5):1752-9.
1998: C M Anderson; Antonio C Buzaid; J Sussman; J Jack Lee; Francis Ali-Osman; Paul Braunschweiger; Carl Plager; Agop Bedikian; Nicholas Papadopoulos; Omar Eton; Sewa S Legha; Elizabeth A Grimm
Nitric oxide and neopterin levels and clinical response in stage III melanoma patients receiving concurrent biochemotherapy.
Melanoma research 1998;8(2):149-55.
1998: Antonio C Buzaid; Francis Ali-Osman; N Akande; Elizabeth A Grimm; J Jack Lee; Agop Bedikian; Omar Eton; Nicholas Papadopoulos; Carl Plager; Sewa S Legha; Robert S Benjamin
DNA damage in peripheral blood mononuclear cells correlates with response to biochemotherapy in melanoma.
Melanoma research 1998;8(2):145-8.
1998: Omar Eton; D D Kharkevitch; MA Gianan; Merrick I Ross; K Itoh; Michael William Pride; Cherrie Donawho; Antonio C Buzaid; Paul F Mansfield; Jeffrey E Lee; Sewa S Legha; Carl Plager; Nicholas E Papadopoulos; Agop Bedikian; Robert S Benjamin; Charles M Balch
Active immunotherapy with ultraviolet B-irradiated autologous whole melanoma cells plus DETOX in patients with metastatic melanoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):619-27.
1998: Omar Eton; Sewa S Legha; Thomas E Moon; Antonio C Buzaid; Nicholas E Papadopoulos; Carl Plager; A M Burgess; Agop Bedikian; Sigrid E Ring; Qiong Dong; Armand B. Glassman; Charles M Balch; Robert S Benjamin
Prognostic factors for survival of patients treated systemically for disseminated melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):1103-11.
1998: Shreyaskumar R Patel; Michael A Burgess; Nicholas Papadopolous; G Sidhu; R Gray; Carl Plager; Jan Jenkins; Robert S Benjamin
Phase II study of CI-980 (NSC 635370) in patients with previously treated advanced soft-tissue sarcomas.
Investigational new drugs 1998;16(1):87-92.
1997: Sewa S Legha; Sigrid E Ring; Omar Eton; Agop Bedikian; Carl Plager; Nicholas Papadopoulos
Development and results of biochemotherapy in metastatic melanoma: the University of Texas M.D. Anderson Cancer Center experience.
The cancer journal from Scientific American 1997;3 Suppl 1():S9-15.
1997: Shreyaskumar R Patel; Saroj Vadhan-Raj; Nicholas Papadopolous; Carl Plager; Michael A Burgess; C Hays; Robert S Benjamin
High-dose ifosfamide in bone and soft tissue sarcomas: results of phase II and pilot studies--dose-response and schedule dependence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2378-84.
1997: Antonio C Buzaid; Merrick I Ross; Charles M Balch; Seng-Jaw Soong; William H McCarthy; L Tinoco; Paul Mansfield; Jeffrey E Lee; Agop Bedikian; Omar Eton; Carl Plager; Nicholas Papadopoulos; Sewa S Legha; Robert S Benjamin
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(3):1039-51.
1997: Shreyaskumar R Patel; K A Linke; Michael A Burgess; Nicholas E Papadopoulos; Carl Plager; Jan Jenkins; R Benjamin
Phase II Study of Paclitaxel in Patients With Soft Tissue Sarcomas.
Sarcoma 1997;1(2):95-7.
1996: Sewa S Legha; Sigrid E Ring; Agop Bedikian; Carl Plager; Omar Eton; Antonio C Buzaid; Nicholas Papadopoulos
Treatment of metastatic melanoma with combined chemotherapy containing cisplatin, vinblastine and dacarbazine (CVD) and biotherapy using interleukin-2 and interferon-alpha.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1996;7(8):827-35.
1996: Shreyaskumar R Patel; Nicholas E Papadopoulos; Carl Plager; K A Linke; S H Moseley; C H Spirindonidis; R Benjamin
Phase II study of paclitaxel in patients with previously treated osteosarcoma and its variants.
Cancer 1996;78(4):741-4.
1996: Sewa S Legha; MA Gianan; Carl Plager; Omar Eton; N E Papadopoulous
Evaluation of interleukin-2 administered by continuous infusion in patients with metastatic melanoma.
Cancer 1996;77(1):89-96.
1995: Shreyaskumar R Patel; Carl Plager; Nicholas E Papadopoulos; Robert S Benjamin
Myxoid malignant fibrous histiocytoma: experience with chemotherapy.
American journal of clinical oncology 1995;18(6):528-31.
1995: Agop Bedikian; Sewa S Legha; G Mavligit; C H Carrasco; S Khorana; Carl Plager; Nicholas Papadopoulos; Robert S Benjamin
Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors.
Cancer 1995;76(9):1665-70.
1995: Saroj Vadhan-Raj; H E Broxmeyer; Michael Andreeff; J C Bandres; E Stephen Buescher; Robert S Benjamin; Nicholas E Papadopoulos; A Burgess; Shreyaskumar Patel; Carl Plager; Walter N Hittelman; I McAlister; L Garrison; D E Williams
In vivo biologic effects of PIXY321, a synthetic hybrid protein of recombinant human granulocyte-macrophage colony-stimulating factor and interleukin-3 in cancer patients with normal hematopoiesis: a phase I study.
Blood 1995;86(6):2098-105.
1994: Antonio C Buzaid; Sewa S Legha; Charles M Balch; M Ross; Sigrid E Ring; Carl Plager; Nicholas E Papadopoulos; Adel K El-Naggar; Robert S Benjamin
Pilot study of preoperative chemotherapy with cisplatin, vinblastine, and dacarbazine in patients with local-regional recurrence of melanoma.
Cancer 1994;74(9):2476-82.
1994: Antonio C Buzaid; Elizabeth A Grimm; Francis Ali-Osman; Sigrid E Ring; Omar Eton; Nicholas E Papadopoulos; Agop Bedikian; Carl Plager; Sewa S Legha; R Benjamin
Mechanism of the anti-tumour effect of biochemotherapy in melanoma: preliminary results.
Melanoma research 1994;4(5):327-30.
1994: Shreyaskumar R Patel; Michael A Burgess; Carl Plager; Nicholas E Papadopoulos; K A Linke; Robert S Benjamin
Myxoid liposarcoma. Experience with chemotherapy.
Cancer 1994;74(4):1265-9.
1994: Saroj Vadhan-Raj; Nicholas E Papadopoulos; Michael A Burgess; K A Linke; Shreyaskumar R Patel; C Hays; A Arcenas; Carl Plager; Andrzej P Kudelka; Walter N Hittelman
Effects of PIXY321, a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein, on chemotherapy-induced multilineage myelosuppression in patients with sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(4):715-24.
1994: Charles Koller; C C Gorski; Robert S Benjamin; Sewa S Legha; Nicholas E Papadopoulos; Carl Plager
A phase I trial of weekly lomustine in patients with advanced cancer.
Cancer 1994;73(1):236-9.
1993: C F Verschraegen; Sewa S Legha; Evan M Hersh; Carl Plager; Nicholas Papadopoulos; M A Burgess
Phase II study of vindesine and dacarbazine with or without non-specific stimulation of the immune system in patients with metastatic melanoma.
European journal of cancer (Oxford, England : 1990) 1993;29A(5):708-11.
1990: Lynn Feun; Y Y Lee; Carl Plager; Nicholas Papadopoulos; Niramol Savaraj; C Charnsangavej; Robert S Benjamin; S Wallace
Intracarotid cisplatin-based chemotherapy in patients with malignant melanoma and central nervous system (CNS) metastases.
American journal of clinical oncology 1990;13(5):448-51.
1990: L M Lamki; A A Zukiwski; L J Shanken; Sewa S Legha; Robert S Benjamin; Carl Plager; D F Salk; R W Schroff; James L Murray
Radioimaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen.
Cancer research 1990;50(3 Suppl):904s-908s.
1990: Gerald P Bodey; V Fainstein; Linda S Elting; E Anaissie; Kenneth Rolston; Nancy Khardori; Andrew Lamb; Carl Plager; WK Murphy; Frankie A Holmes
Beta-lactam regimens for the febrile neutropenic patient.
Cancer 1990;65(1):9-16.
1989: Sewa S Legha; Sigrid E Ring; Nicholas Papadopoulos; Carl Plager; S Chawla; R Benjamin
A prospective evaluation of a triple-drug regimen containing cisplatin, vinblastine, and dacarbazine (CVD) for metastatic melanoma.
Cancer 1989;64(10):2024-9.
1989: K H Lee; Moshe Talpaz; J M Rothberg; James L Murray; Nicholas Papadopoulos; Carl Plager; R Benjamin; D Levitt; Jordan U Gutterman
Concomitant administration of recombinant human interleukin-2 and recombinant interferon alpha-2A in cancer patients: a phase I study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(11):1726-32.
1989: Marvin L Meistrich; S P Chawla; M F Da Cunha; S L Johnson; Carl Plager; Nicholas E Papadopoulos; L I Lipshultz; Robert S Benjamin
Recovery of sperm production after chemotherapy for osteosarcoma.
Cancer 1989;63(11):2115-23.
1989: Nelson G Ordóñez; Alberto G Ayala; A K Raymond; Carl Plager; R S Benjamin; N A Samaan
Ectopic production of the beta-subunit of human chorionic gonadotropin in osteosarcoma.
Archives of pathology & laboratory medicine 1989;113(4):416-9.
1988: James L Murray; L M Lamki; L J Shanken; M E Blake; Carl Plager; Robert S Benjamin; S Schweighardt; M W Unger; Michael G Rosenblum
Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans.
Cancer research 1988;48(15):4417-22.
1987: Sewa S Legha; Nicholas E Papadopoulos; Carl Plager; Sigrid E Ring; S P Chawla; L M Evans; Robert S Benjamin
Clinical evaluation of recombinant interferon alfa-2a (Roferon-A) in metastatic melanoma using two different schedules .
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(8):1240-6.
1987: A Kevin Raymond; S P Chawla; C H Carrasco; Alberto G Ayala; Christina V Fanning; B Grice; T Armen; Carl Plager; Nicholas E Papadopoulos; J Edeiken
Osteosarcoma chemotherapy effect: a prognostic factor.
Seminars in diagnostic pathology 1987;4(3):212-36.
1987: James L Murray; Michael G Rosenblum; L Lamki; T P Haynie; H J Glenn; Carl Plager; M W Unger; Dennis J Carlo; Evan M Hersh
Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen.
NCI monographs : a publication of the National Cancer Institute 1987;(3):3-9.
1987: James L Murray; Michael G Rosenblum; L Lamki; H J Glenn; Z Krizan; Evan M Hersh; Carl Plager; Richard Bartholomew; M W Unger; Dennis J Carlo
Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(1):25-33.
1986: G N Hortobagyi; Evan M Hersh; Nicholas E Papadopoulos; D Frye; A Rios; J M Reuben; Carl Plager; M Rosenblum; J Quesada
Initial clinical studies with copovithane.
Journal of biological response modifiers 1986;5(4):319-29.
1986: Moshe Talpaz; Carl Plager; J Quesada; R Benjamin; H Kantarjian; J Gutterman
Difluoromethylornithine and leukocyte interferon: a phase I study in cancer patients.
European journal of cancer & clinical oncology 1986;22(6):685-9.
1985: L D Feldman; Lynn Feun; Robert S Benjamin; B S Yap; Carl Plager; Nicholas Papadopoulos; Niramol Savaraj; M A Burgess; Gerald P Bodey
A phase II trial of PCNU in patients with malignant melanoma and central nervous system metastases.
American journal of clinical oncology 1985;8(3):215-7.
1985: James L Murray; Michael G Rosenblum; R E Sobol; Richard Bartholomew; Carl Plager; T P Haynie; M F Jahns; H J Glenn; L Lamki; Robert S Benjamin
Radioimmunoimaging in malignant melanoma with 111In-labeled monoclonal antibody 96.5.
Cancer research 1985;45(5):2376-81.
1984: R Kurzrock; B S Yap; Carl Plager; N Papdopoulos; Robert S Benjamin; Manuel Valdivieso; Gerald P Bodey
Phase II evaluation of PALA in patients with refractory metastatic sarcomas.
American journal of clinical oncology 1984;7(4):305-7.
1983: B S Yap; Robert S Benjamin; Carl Plager; M A Burgess; N Papadoupoulos; Gerald P Bodey
A randomized study of continuous infusion vindesine versus vinblastine in adults with refractory metastatic sarcomas.
American journal of clinical oncology 1983;6(2):235-8.
1981: B S Yap; Carl Plager; Robert S Benjamin; WK Murphy; Sewa S Legha; Gerald P Bodey
Phase II evaluation of AMSA in adult sarcomas.
Cancer treatment reports 1981;65(3-4):341-3.